{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:55Z","timestamp":1792682815177,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10048-022-00688-3","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T06:02:27Z","timestamp":1649484147000},"page":"167-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2305-1073","authenticated-orcid":false,"given":"H\u00e9lio A. G.","family":"Teive","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3533-0347","authenticated-orcid":false,"given":"Carlos Henrique F.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4921-2939","authenticated-orcid":false,"given":"L\u00e9o","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4783-4067","authenticated-orcid":false,"given":"Renato P.","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"688_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2017.10.010","volume":"383","author":"D Burguez","year":"2017","unstructured":"Burguez D, Polese-Bonatto M, Scudeiro LAJ et al (2017) Clinical and molecular characterization of hereditary spastic-paraplegias: a next-generation sequencing panel approach. J Neurol Sci 383:18\u201325","journal-title":"J Neurol Sci"},{"issue":"2","key":"688_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","volume":"16","author":"PVS de Souza","year":"2017","unstructured":"de Souza PVS, Pinto WBVR, Batistella GNR, Botholin T, Oliveira ASB (2017) Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum 16(2):525\u2013551","journal-title":"Cerebellum"},{"key":"688_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","volume":"261","author":"T Lo Giudice","year":"2014","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A (2014) Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol 261:518\u2013539","journal-title":"Exp Neurol"},{"issue":"3","key":"688_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/mds.26944","volume":"32","author":"M Synofzik","year":"2017","unstructured":"Synofzik M, Sch\u00fcle R (2017) Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes and pathways. Mov Disord 32(3):332\u2013345","journal-title":"Mov Disord"},{"key":"688_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/B978-0-444-53486-6.00038-7","volume":"136","author":"P Hedera","year":"2016","unstructured":"Hedera P (2016) Hereditary and metabolic myelopathies. Handb Clin Neurol 136:769\u2013785","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"688_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126(3):307\u2013328","journal-title":"Acta Neuropathol"},{"key":"688_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/WCO.0b013e3282f190ba","volume":"20","author":"C Depienne","year":"2007","unstructured":"Depienne C, Stevanin G, Brice A, Durr A (2007) Hereditary spastic paraplegia: an update. Curr Opin Neurol 20:674\u2013680","journal-title":"Curr Opin Neurol"},{"issue":"21","key":"688_CR8","first-page":"00735","volume":"S1096\u20137192","author":"D Ebrahimi-Fakhari","year":"2021","unstructured":"Ebrahimi-Fakhari D, Saffari A, Pearl PL (2021) Childhood-onset hereditary spastic paraplegia and its treatable mimics. Mol Genet Metab S1096\u20137192(21):00735\u201300736","journal-title":"Mol Genet Metab"},{"key":"688_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/mds.27568","volume":"34","author":"D Ebrahimi-Fakhari","year":"2019","unstructured":"Ebrahimi-Fakhari D, van Karnebeek C, M\u00fcnchau A (2019) Movement disorders in treatable inborn errors of metabolism. Mov Disord 34:598\u2013613","journal-title":"Mov Disord"},{"key":"688_CR10","doi-asserted-by":"publisher","first-page":"582160","DOI":"10.3389\/fneu.2020.582160","volume":"11","author":"JD Ortigoza-Escobar","year":"2020","unstructured":"Ortigoza-Escobar JD (2020) A proposed diagnostic algorithm for inborn errors of metabolism presenting with movement disorders. Front Neurol 11:582160. https:\/\/doi.org\/10.3389\/fneu.2020.582160","journal-title":"Front Neurol"},{"key":"688_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/WNL.0b013e31826d5fb0","volume":"79","author":"ST de Bolt","year":"2012","unstructured":"de Bolt ST, Willemsen MAAP, Vermeer S, Kremer HPH, van de Warremburg BPC (2012) Reviewing the genetic causes of spastic-ataxias. Neurology 79:1507\u20131514","journal-title":"Neurology"},{"key":"688_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/mds.27655","volume":"34","author":"TS Pearson","year":"2019","unstructured":"Pearson TS, Pons R, Ghaoui R, Sue CM (2019) Genetic mimics of cerebral palsy. Mov Disord 34:625\u2013635","journal-title":"Mov Disord"},{"issue":"2","key":"688_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/jnnp-2018-318666","volume":"90","author":"C Marelli","year":"2019","unstructured":"Marelli C, Salsano E, Politi LS, Labauge P (2019) Spinal cord involvement in adult-onset metabolic and genetic diseases. J Neurol Neurosurg Pstchiatry 90(2):211\u2013218","journal-title":"J Neurol Neurosurg Pstchiatry"},{"issue":"1","key":"688_CR14","first-page":"185","volume":"27","author":"J Fink","year":"2021","unstructured":"Fink J (2021) Hereditary myelopathies. Continuum (Minneap Minn) 27(1):185\u2013204","journal-title":"Continuum (Minneap Minn)"},{"key":"688_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/practneurol-2016-001485","volume":"17","author":"L Ginsberg","year":"2017","unstructured":"Ginsberg L (2017) Myelopathy: chameleons and mimics. Pract Neurol 17:6\u201312","journal-title":"Pract Neurol"},{"key":"688_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/practneurol-2011-000069","volume":"11","author":"L Ginsberg","year":"2011","unstructured":"Ginsberg L (2011) Disorders of the spinal cord and roots. Pract Neurol 11:259\u2013267","journal-title":"Pract Neurol"},{"key":"688_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/jnnp.2008.144121","volume":"8","author":"SH Wong","year":"2008","unstructured":"Wong SH, Boggild M, Enevoldson TP et al (2008) Myelopathy but normal MRI: where the next? Pract Neurol 8:90\u2013102","journal-title":"Pract Neurol"},{"issue":"10","key":"688_CR18","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/s00415-019-09432-8","volume":"266","author":"Y Wei","year":"2019","unstructured":"Wei Y, Zhou Y, Yuan J, Ni J, Qian M, Cui L, Peng B (2019) Treatable cause of hereditary spastic paraplegia: eight cases of combined homocysteinaemia with methylmalonic aciduria. J Neurol 266(10):2434\u20132439","journal-title":"J Neurol"},{"issue":"16","key":"688_CR19","first-page":"473","volume":"84","author":"W Waespe","year":"1995","unstructured":"Waespe W, Wigger BMV, B\u00e4chli E, Boltshauser E (1995) Differential diagnosis aspects of progressive spastic paraplegia in adults with emphasis on neurometabolic diseases. Praxis (Berlim) 84(16):473\u2013477","journal-title":"Praxis (Berlim)"},{"issue":"16","key":"688_CR20","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2174\/0929867325666180313105949","volume":"26","author":"BL Zaric","year":"2019","unstructured":"Zaric BL, Obradovic M, Bajic V, Haidara MA, Jonanovic M, Isenbovic ER (2019) Homocysteine and hyperhomocysteinaemia. Curr Med Chem 26(16):2948\u20132961","journal-title":"Curr Med Chem"},{"issue":"14","key":"688_CR21","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.2174\/1381612811319140008","volume":"19","author":"EE Trimmer","year":"2013","unstructured":"Trimmer EE (2013) Methylenetetrahydrofolate reductase: biochemical characterization and medical significance. Curr Pharm Des 19(14):2574\u20132593","journal-title":"Curr Pharm Des"},{"issue":"1","key":"688_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-018-0767-9","volume":"13","author":"A Gales","year":"2018","unstructured":"Gales A, Masingue M, Milecamps S et al (2018) Adolescence\/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes. Orphanet J Rare Dis 13(1):29. https:\/\/doi.org\/10.1186\/s13023-018-0767-9","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"688_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10897-016-9956-7","volume":"25","author":"BL Levin","year":"2016","unstructured":"Levin BL, Varga E (2016) MTHFR: addressing genetic counseling dilemmas using evidence-based literature. J Genet Couns 25(5):901\u2013911","journal-title":"J Genet Couns"},{"issue":"3","key":"688_CR24","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/ene.13557","volume":"25","author":"A Perna","year":"2018","unstructured":"Perna A, Masciullo M, Modoni A, Cellini E, Parrini E, Ricci E, Donati AM, Silvestri G (2018) Severe 5,10-methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia. Eur J Neurol 25(3):602\u2013605","journal-title":"Eur J Neurol"},{"issue":"7","key":"688_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jamaneurol.2014.116","volume":"71","author":"A Lossos","year":"2014","unstructured":"Lossos A, Teltsh O, Milman T et al (2014) Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia. JAMA Neurol 71(7):901\u2013904","journal-title":"JAMA Neurol"},{"issue":"2","key":"688_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaneurol.2013.4915","volume":"71","author":"EF Diekman","year":"2014","unstructured":"Diekman EF et al (2014) Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. JAMA Neurol 71(2):188\u2013194","journal-title":"JAMA Neurol"},{"key":"688_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","volume":"40","author":"M Huemer","year":"2017","unstructured":"Huemer M et al (2017) Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis 40:21\u201348","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"688_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/humu.22970","volume":"37","author":"DS Froese","year":"2016","unstructured":"Froese DS, Huemer M, Suormala T et al (2016) Mutation update and review of severe methylenetetrahydrofolate reductase deficiency. Hum Mutat 37(5):427\u2013438","journal-title":"Hum Mutat"},{"issue":"8","key":"688_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/WNL.56.8.1113","volume":"56","author":"AO Bodamer","year":"2001","unstructured":"Bodamer AO, Rosenblatt DS, Appel SH, Beaudet AL (2001) Adult-onset combined methylmalonic aciduria and homocystinuria (cblC). Neurology 56(8):1113","journal-title":"Neurology"},{"issue":"3","key":"688_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ymgme.2013.07.018","volume":"110","author":"JD Weinsfeld-Adams","year":"2013","unstructured":"Weinsfeld-Adams JD, Bender H\u00c1, Miley-Akerstedt A et al (2013) Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab 110(3):241\u2013247","journal-title":"Mol Genet Metab"},{"issue":"6","key":"688_CR31","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1002\/mgg3.1221","volume":"8","author":"C Wang","year":"2020","unstructured":"Wang C, Liu Y, Cai F et al (2020) Rapid screening of MMACHC gene mutations by high-resolution melting curve analysis. Mol Genet Genomic Med 8(6):e1221","journal-title":"Mol Genet Genomic Med"},{"issue":"39","key":"688_CR32","doi-asserted-by":"publisher","first-page":"e17334","DOI":"10.1097\/MD.0000000000017334","volume":"98","author":"J Cui","year":"2019","unstructured":"Cui J, Wang Y, Zhang H, Cui X, Wang L, Zheng H (2019) Isolated subacute combined degeneration in late-onset cobalamin C deficiency in children: two case reports and literature review. Medicine (Baltimore) 98(39):e17334","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"688_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s007020200026","volume":"109","author":"U M\u00fcller","year":"2002","unstructured":"M\u00fcller U, Steinberger D, Topka H (2002) Mutations of GCH1 in dopa-responsive dystonia. J Neural Transm (Vienna) 109(3):321\u2013328","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"688_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/mdc3.12211","volume":"2","author":"E Antelmi","year":"2015","unstructured":"Antelmi E, Stamelou M, Liguori R, Bhatia KP (2015) Nonmotor symptoms in dopa-responsive dystonia. Mov Disor Clin Pract 2(4):347\u2013356","journal-title":"Mov Disor Clin Pract"},{"issue":"7","key":"688_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","volume":"11","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Jankovic J (2015) Dopa-responsive dystonia \u2013 clinical and genetic heterogeneity. Nat Rev Neurol 11(7):414\u2013424","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"688_CR36","doi-asserted-by":"publisher","first-page":"e00906","DOI":"10.1002\/brb3.906","volume":"8","author":"YC Weng","year":"2018","unstructured":"Weng YC, Wang CC, Wu YR (2018) Atypical presentation of dopa-responsive dystonia in Taiwan. Brain Behav 8(2):e00906","journal-title":"Brain Behav"},{"key":"688_CR37","doi-asserted-by":"publisher","unstructured":"Varghaei P, Yoon G, Estiar MA, Veyron S, Leveille E, Dupre N, Trempe JF, Rouleau GA, Gan\u2010Or Z. GCH1 mutations in hereditary spastic paraplegia. Clin Genet. 2021. https:\/\/doi.org\/10.1111\/cge.13955. Epub ahead of print.","DOI":"10.1111\/cge.13955"},{"issue":"3","key":"688_CR38","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00415-014-7265-3","volume":"261","author":"Z Fan","year":"2014","unstructured":"Fan Z, Greenwood R, Felix ACG et al (2014) GCH1 heterozygous mutation identified by whole-exome-sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia. J Neurol 261(3):622\u2013624","journal-title":"J Neurol"},{"key":"688_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.03.019","volume":"74","author":"T Wassemberg","year":"2020","unstructured":"Wassemberg T, Schouten MI, Helmich RC, Willemsen MAAP, Kamsteeg EJ, van de Warrenburg BPC (2020) Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset. Parkinsonism Relat Disord 74:12\u201315","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"688_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","volume":"27","author":"GN Gallus","year":"2006","unstructured":"Gallus GN, Dotti MT, Federico A (2006) Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 27(2):143\u2013149","journal-title":"Neurol Sci"},{"issue":"6","key":"688_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","volume":"40","author":"G Salen","year":"2017","unstructured":"Salen G, Steiner RD (2017) Epidemiology, diagnosis and treatment of cerebrotendinous xnahtomatosis (CTX). J Inherit Metab Dis 40(6):771\u2013781","journal-title":"J Inherit Metab Dis"},{"key":"688_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13023-014-0179-4","volume":"9","author":"S Nie","year":"2014","unstructured":"Nie S, Chen G, Cao X, Zhang Y (2014) Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 9:179. https:\/\/doi.org\/10.1186\/s13023-014-0179-4","journal-title":"Orphanet J Rare Dis"},{"key":"688_CR43","unstructured":"Laurent A, Dairou F, Luc G, Truffert J, Lapresle J, de Genners JL. van Bogaert\u00b4s cerebrotendinous xanthomatosis. A study of 3 cases. Ann Med Interne (Paris) 1988; 139 (6): 395\u2013402."},{"key":"688_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2018.07.006","volume":"58","author":"BML Stelten","year":"2019","unstructured":"Stelten BML, van de Warremburg BPC, Wevers RA, Verrips A (2019) Movement disorders in cerebrotendinous xanthomatosis. Parkinsonism Relat Disord 58:12\u201316","journal-title":"Parkinsonism Relat Disord"},{"key":"688_CR45","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","volume":"18","author":"B Pilo-de-la-Fuente","year":"2011","unstructured":"Pilo-de-la-Fuente B, Jimenez-Escrig A, Lorenzo JR et al (2011) Cerebrotendineous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol 18:1203\u20131211","journal-title":"Eur J Neurol"},{"issue":"2","key":"688_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10545-014-9745-0","volume":"38","author":"JA Saute","year":"2015","unstructured":"Saute JA, Giugliani R, Merkens LS, Chiang JPW, De Barber AE, de Souza CFM (2015) Look carefully to the heels! A potentially treatable cause of spastic paraplegia. J Inherit Metab Dis 38(2):363\u2013364","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"688_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/practneurol-2015-001117","volume":"15","author":"Z Nicholls","year":"2015","unstructured":"Nicholls Z, Hobson E, Martindale J, Shaw PJ (2015) Diagnosis of spinal xanthomatosis by next-generation sequencing: identifying a rare, treatable mimic of hereditary spastic paraparesis. Pract Neurol 15(4):280\u2013283","journal-title":"Pract Neurol"},{"issue":"4","key":"688_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10072-019-04169-8","volume":"41","author":"A Verrips","year":"2020","unstructured":"Verrips A et al (2020) The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies. Neurol Sci 41(4):943\u2013949","journal-title":"Neurol Sci"},{"key":"688_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fneur.2019.00131","volume":"10","author":"E Panza","year":"2019","unstructured":"Panza E, Martinelli D, Magini P, Vici CD, Seri M (2019) Hereditary spastic paraplegia is a common phenotypic finding in ARG1 deficiency, P5CS deficiency and HHH syndrome: three inborn errors of metabolism caused by alteration of an interconnected pathway of glutamate and urea cycle metabolism. Front Neurol 10:131. https:\/\/doi.org\/10.3389\/fneur.2019.00131","journal-title":"Front Neurol"},{"issue":"Pt 1","key":"688_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv247","volume":"139","author":"E Panza","year":"2016","unstructured":"Panza E, Escamilla-Honrubia JM, Marco-Mar\u00edn C et al (2016) ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism. Brain 139(Pt 1):e3. https:\/\/doi.org\/10.1093\/brain\/awv247","journal-title":"Brain"},{"key":"688_CR51","doi-asserted-by":"publisher","unstructured":"Coutelier M, Goizet C, Alexandra Durr et al. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain 2015; 138 (Pt 8): 2191\u20132195. https:\/\/doi.org\/10.1093\/brain\/awv143.","DOI":"10.1093\/brain\/awv143"},{"issue":"5","key":"688_CR52","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10545-011-9411-8","volume":"35","author":"D Martinelli","year":"2012","unstructured":"Martinelli D et al (2012) Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine. J Inherit Metab Dis 35(5):761\u2013776","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"688_CR53","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J et al (2019) Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis 42(6):1192\u20131230","journal-title":"J Inherit Metab Dis"},{"key":"688_CR54","first-page":"117","volume":"36","author":"P Ferreira","year":"2017","unstructured":"Ferreira P, Chan A, Wolf B (2017) Irreversibility of symptoms with biotin therapy in an adult with profound biotinidase deficiency. J Inherit Metab Dis Rep 36:117\u2013120","journal-title":"J Inherit Metab Dis Rep"},{"key":"688_CR55","doi-asserted-by":"publisher","first-page":"100689","DOI":"10.1016\/j.ymgmr.2020.100689","volume":"25","author":"S Funghini","year":"2020","unstructured":"Funghini S, Tonin R, Malvagia S et al (2020) High frequency of biotinidase deficiency in Italian population identified by newborn screening. Mol Genet Metab Rep 25:100689. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100689","journal-title":"Mol Genet Metab Rep"},{"issue":"1\u20132","key":"688_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2011.06.001","volume":"104","author":"B Wolf","year":"2011","unstructured":"Wolf B (2011) The neurology of biotinidase deficiency. Mol Genet Metab 104(1\u20132):27\u201334","journal-title":"Mol Genet Metab"},{"issue":"1","key":"688_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0887-8994(03)00042-0","volume":"29","author":"M Wiznitzer","year":"2003","unstructured":"Wiznitzer M, Bangert BA (2003) Biotinidase deficiency: clinical and MRI findings consistent with myelopathy. Pediatr Neurol 29(1):56\u201358","journal-title":"Pediatr Neurol"},{"issue":"6","key":"688_CR58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2011.6","volume":"14","author":"B Wolf","year":"2012","unstructured":"Wolf B (2012) Biotinidase deficiency: \u201cif you have to have an inherited metabolic Disease, this is the one to have.\u201d Genet Med 14(6):565\u2013575","journal-title":"Genet Med"},{"issue":"3","key":"688_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11011-017-9984-5","volume":"32","author":"S Yilmaz","year":"2017","unstructured":"Yilmaz S, Serin M, Canda E, Eraslan C, Tekin H, Ucar SK, Gokben S, Tekgul H, Serdaroglu G (2017) A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency. Metab Brain Dis 32(3):675\u2013678","journal-title":"Metab Brain Dis"},{"issue":"2","key":"688_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/088307389400900213","volume":"9","author":"M Livne","year":"1994","unstructured":"Livne M, Gibson KM, Amir N, Eshel G, Elpeleg ON (1994) Holocarboxylase synthetase deficiency: a treatable metabolic disorder masquerading as cerebral palsy. J Child Neurol 9(2):170\u2013172","journal-title":"J Child Neurol"},{"issue":"6","key":"688_CR61","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ejpn.2011.04.012","volume":"15","author":"M Komur","year":"2011","unstructured":"Komur M, Okuyaz C, Ezgu F, Atici A (2011) A girl with spastic tetraparesis associated with biotinidase deficiency. Eur J Paediatr Neurol 15(6):551\u2013553","journal-title":"Eur J Paediatr Neurol"},{"key":"688_CR62","doi-asserted-by":"crossref","unstructured":"Wolf B. \u201cThink metabolic\u201d in adults with diagnostic challenges. Biotinidase deficiency as a paradigm disorder. Neurol Clin Pract 2017; 7 (6): 518\u2013522.","DOI":"10.1212\/CPJ.0000000000000379"},{"issue":"4","key":"688_CR63","first-page":"396","volume":"19","author":"B Wolf","year":"2017","unstructured":"Wolf B (2017) Successful outcomes of older adolescents and adults with profound biotinidase deficiency identified by newborn screening. Genet Metab 19(4):396\u2013402","journal-title":"Genet Metab"},{"key":"688_CR64","doi-asserted-by":"crossref","unstructured":"Suormala T, Fowler B, Duran M, et al. Five patients with a biotin-responsive defect. In holocarboxylase formation: evaluation of responsiveness to biotin therapy in vivo and comparative biochemical studies in vitro. Pediatr Res 1007; 41 (5): 666\u2013673.","DOI":"10.1203\/00006450-199705000-00011"},{"issue":"1","key":"688_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgme.2010.01.003","volume":"100","author":"B Wolf","year":"2010","unstructured":"Wolf B (2010) Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab 100(1):6\u201313","journal-title":"Mol Genet Metab"},{"issue":"12","key":"688_CR66","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1177\/1352458515596457","volume":"21","author":"L Bottin","year":"2015","unstructured":"Bottin L et al (2015) Biotinidase deficiency mimicking neuromyelitis optica: initially exhibiting symptoms in adulthood. Mult Scler 21(12):1604\u20131607","journal-title":"Mult Scler"},{"issue":"3","key":"688_CR67","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/epi4.12414","volume":"5","author":"J Klepper","year":"2020","unstructured":"Klepper J, Akman C, Armeno M et al (2020) Glut1 deficiency syndrome (Glut1DS): state of the art in 2020 and recommendations of the International Glut1DS study group. Epilepsia Open 5(3):354\u2013365","journal-title":"Epilepsia Open"},{"issue":"2","key":"688_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neurol.2013.09.005","volume":"170","author":"D Gras","year":"2014","unstructured":"Gras D, Roze E, Caillet S et al (2014) GLUT1 deficiency syndrome: an update. Rev Neurol (Paris) 170(2):91\u201399","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"688_CR69","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s11910-013-0342-7","volume":"13","author":"TS Pearson","year":"2013","unstructured":"Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC (2013) Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 13(4):342","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"688_CR70","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/eje.0.1500627","volume":"150","author":"JM Pascual","year":"2004","unstructured":"Pascual JM, Wang D, Lecumberri B et al (2004) GLUT1 deficiency and other glucose transport diseases. Eur J Endocrinol 150(5):627\u2013633","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"688_CR71","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ejmg.2016.10.003","volume":"59","author":"M Diomedi","year":"2016","unstructured":"Diomedi M, Gan-Or Z, Placidi F et al (2016) A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia. Eur J Med Genet 59(11):564\u2013568","journal-title":"Eur J Med Genet"},{"issue":"2","key":"688_CR72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejpn.2019.02.010","volume":"23","author":"A Verroti","year":"2019","unstructured":"Verroti A, Di Francesco L, Striano P (2019) GLUT1 deficiency and pediatric-onset hereditary spastic paraplegia: a new classification. Eur J Paediatr Neurol 23(2):233\u2013234","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"688_CR73","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ejpn.2018.12.004","volume":"23","author":"F Nicita","year":"2019","unstructured":"Nicita F, Schirinzi T, Stregapede F, Vasco G, Bertini E, Travaglini L (2019) SLCA1 mutations are a cause of pediatric-onset hereditary spastic paraplegia. Eur J Paediatr Neurol 23(2):329\u2013332","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"688_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/mdc3.12858","volume":"7","author":"VB Ciarlariello","year":"2019","unstructured":"Ciarlariello VB, Freitas JL, Pedroso JL, Barsottini OGP (2019) X-linked adrenoleukodystrophy mimicking hereditary spastic paraplegia. Mov Disord Clin Pract 7(1):109\u2013110","journal-title":"Mov Disord Clin Pract"},{"issue":"1","key":"688_CR75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jdn.10003","volume":"80","author":"BR Turk","year":"2020","unstructured":"Turk BR, Theda C, Fatemi A, Moser AB (2020) X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci 80(1):52\u201372","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"688_CR76","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00415-009-5358-1","volume":"257","author":"G Jousserand","year":"2010","unstructured":"Jousserand G, Antoine JC, Camdessanch\u00e9 JP (2010) Musty odour, mental retardation, and spastic paraplegia revealing phenylketonuria in adulthood. J Neurol 257(2):302\u2013304","journal-title":"J Neurol"},{"key":"688_CR77","unstructured":"Duarte S, Cruz Martins R, Rodrigues M, et al. Association of cerebral folate deficiency and hereditary spastic paraplegia. Neurologia 2020; Oct 16: S0213\u20134853(20)30284-X."}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-022-00688-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T20:52:29Z","timestamp":1700427149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-022-00688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s10048-022-00688-3","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}